Enhanced mechanical strength and decreased tissue irritation from advanced composite materials may boost patient eligibility
As we continue to ascend, it is imperative to remain guided by evidence-based practices, ethical considerations, and a commitment to improving the quality of life across the lifespan
GLP-1 medications like Zepbound are gaining new FDA indications beyond weight loss, including for OSA, cardiovascular risk reduction, and liver disease
Exploring these rare causes requires comprehensive diagnostic evaluations, often involving imaging studies, neurological assessments, and a review of the patients medication regimen
Late fees apply if you miss a payment, currently capped at 25% of the order value or $68, whichever is less
Shira Is an Expert at what she does.